Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pancreatic autoantibodies in inflammatory bowel disease.

Inflammatory bowel diseases - 1 Nov 2004

Joossens Sofie, Vermeire Severine, Van Steen Kristel, Godefridis Godelieve, Claessens Greet, Pierik Marie, Vlietinck Robert, Aerts Raymond, Rutgeerts Paul, Bossuyt Xavier

Abstract excerpt

BACKGROUND: Autoantibodies against exocrine pancreas (PABs) have been reported to be specific for Crohn's disease (CD), albeit at a low prevalence (30%). We studied PABs in patients with inflammatory bowel disease (IBD), unaffected family members, and control subjects. METHODS: A Belgian study cohort of 575 subjects, including 289 IBD patients (CD, 169 patients; ulcerative colitis [UC], 120 patients), 108...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Antineutrophil Cytoplasmic
Share to Belgium

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colitis, Ulcerative

Share to Crohn Disease

Share to Fluorescent Antibody Technique, Indirect

Share to Islets of Langerhans

Share to Prevalence

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 15626896
DOI: 10.1097/00054725-200411000-00012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pancreatic autoantibodies in inflammatory bowel disease.PMID 15626896Read ↗

Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort.Semantic proximity Read ↗

Pancreatic Associated Manifestations in Pediatric Inflammatory Bowel Diseases.Semantic proximity Read ↗

Pancreatic Autoantibodies Against CUZD1 and GP2 Are Associated with Distinct Clinical Phenotypes of Crohn's Disease.Semantic proximity Read ↗

The role of autoantibodies in inflammatory bowel disease.Semantic proximity Read ↗

Diagnostic and clinical significance of Crohn's disease-specific pancreatic anti-GP2 and anti-CUZD1 antibodies.Semantic proximity Read ↗

Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families.Semantic proximity Read ↗

Dietary antigens in Crohn's disease: antibodies to porcine pancreatic amylase.Semantic proximity Read ↗

Diagnostic utility, disease activity, and disease phenotype correlation of serum ASCA, pANCA, and PR3-ANCA in pediatric inflammatory bowel disease.Semantic proximity Read ↗

Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease.Semantic proximity Read ↗

[Autoantibodies in chronic inflammatory bowel diseases: more than an epiphenomenon?].Semantic proximity Read ↗

Increased antibody response to microbial antigens in patients with Crohn's disease and their unaffected first-degree relatives.Semantic proximity Read ↗

Serological studies in inflammatory bowel disease: how important are they?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.